Is Vigabatrin effective?

Vigabatrin has shown to be effective in treating certain types of epilepsy, especially seizure control in patients with infantile spasms and refractory partial epilepsy. As a drug that inhibits the neurotransmitter γ-aminobutyric acid (GABA) aminotransferase, Vigabatrin reduces neural excitability by increasing the content of GABA in the brain, thereby reducing the frequency of epileptic seizures.

For infantile spasms, Vigabatrin is one of the drugs of choice. Many studies have shown that it is effective in suppressing spasms, especially when treated promptly in the early stages of the disease. Data show that in some cases, vigabatrin can completely eliminate spastic seizures and improve neurodevelopment. This has a positive effect on the baby's long-term quality of life and intellectual development. However, its effects vary from person to person, with some patients experiencing significant improvements after use, while others experience more limited effects.

For patients with refractory partial epilepsy, especially those who are refractory to other drugs, adjuvant treatment with Vigabatrin can significantly reduce seizure frequency. Clinical trials have shown that patients using Vigabatrin have significantly reduced the number of attacks, and some have even achieved complete control. However, treatment of refractory epilepsy is often complex, and the effects of Vigabatrin will vary between individuals.

Although Vigabatrin is effective, its side effects, especially the risk of visual impairment, may affect the durability of the treatment effect. Some patients need to reduce the dose or discontinue medication due to side effects such as visual field defects, thus affecting the continuity of treatment. Therefore, patients should closely monitor changes in vision during medication and conduct regular reexaminations to ensure that side effects are minimized during treatment.

In general, Vigabatrin has a good effect in the treatment of epilepsy and infantile spasms, but its side effects need to be alerted. During treatment, regular monitoring should be carried out under the guidance of a doctor to obtain the best effect.